Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
Neurology(R) Neuroimmunology & Neuroinflammation|December 7, 2019
Neurologic complications of acute hepatitis E virus infectionPaolo Ripellino, Emanuela Pasi, Giorgia Melli, et al.
Neurology|October 16, 2019
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MSMaria A Rocca, Paola Valsasina, Alessandro Meani, et al.
The Lancet. Neurology|July 31, 2023
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation studyAhmed Abdelhak, Franziska Petermeier, Pascal Benkert, et al.
NPJ Parkinson'S Disease|June 15, 2024
Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathiesIlaria Linda Dellarole, Elena Vacchi, Inigo Ruiz-Barrio, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 28, 2022
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre studyMaria A Rocca, Paola Valsasina, Alessandro Meani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activitySofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, et al.
Annals of Neurology|March 16, 2022
Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MSJohanna Oechtering, Therese Lincke, Sabine Schaedelin, et al.
European Journal of Neurology|August 7, 2023
Neuropathies related to hepatitis E virus infection: A prospective, matched case-control studyPaolo Ripellino, Agustina Maria Lascano, Olivier Scheidegger, et al.
Plos One|April 1, 2016
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsGiulio Disanto, Pascal Benkert, Johannes Lorscheider, et al.
Clinical Chemistry and Laboratory Medicine|December 26, 2025
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controlsEline A J Willemse, Sofia Sandgren, Pascal Benkert, et al.
Pageof 17